In English | En español
Questions About Cancer? 1-800-4-CANCER

Research Program Contacts

  • Updated: 04/06/2012

Page Options

  • Print This Page
  • Email This Document

Popular Resources

Related Pages

Find NCI Program Director Contacts for the following Divisions, Centers, and Offices

NCI Divisions

Centers, Offices, and Selected Programs


NCI Divisions

Division of Cancer Biology

DCB supports and coordinates research projects in basic cancer biology at universities, hospitals, research foundations, and businesses across the United States and abroad.
DCB Staff Directory

Cancer Cell Biology
Dr. Barbara Spalholz
301-496-7028
spalholb@mail.nih.gov

Cancer Etiology
Dr. Donald Blair
301-496-7028
blaird@mail.nih.gov

Cancer Immunology and Hematology
Dr. R. Allan Mufson
301-496-7815
mufsona@mail.nih.gov

DNA and Chromosome Aberrations
Dr. Judy Mietz
301-496-9326
mietzj@mail.nih.gov

Integrative Cancer Biology Program
Dr. Daniel Gallahan
301-496-8636
gallahad@mail.nih.gov

Mouse Models of Human Cancers Consortium
Dr. Cheryl Marks
301-594-8778
marksc@mail.nih.gov

Structural Biology and Molecular Applications
Dr. Jennifer Couch
301-435-5226
couchj@mail.nih.gov

Tumor Biology and Metastasis
Dr. Suresh Mohla
301-435-1878
mohlas@mail.nih.gov

Tumor Microenvironment Network
Dr. Suresh Mohla
301-435-1878
mohlas@mail.nih.gov


Division of Cancer Control & Population Sciences

DCCPS supports a comprehensive program of genetic, epidemiologic, behavioral, social, and surveillance cancer research.
DCCPS Staff Directory

Process of Care Research
Dr. Steven Taplin
301-402-1483
taplins@mail.nih.gov

Basic Biobehavioral and Psychological Sciences
Dr. Paige McDonald
301-435-5037
mcdonalp@mail.nih.gov

Cancer Statistics
Dr. Kathleen Cronin
301-435-2792
cronink@mail.nih.gov

Data Modeling
Dr. Angela Mariotto
301-435-4923
Angela_mariotto@nih.gov

Cancer Survivorship
Dr. Julia Rowland
301-402-2746
rowlandj@mail.nih.gov

Clinical and Translational Epidemiology
Dr. Andrew Freedman
301-435-6819
freedmaa@mail.nih.gov

Implementation Science
Dr. Russell Glasgow
301-435-4912
cvinson@mail.nih.gov

Health Communication and Informatics
Dr. Bradford W. Hesse
301-594-9904
hesseb@mail.nih.gov

Health Behaviors
Dr. Linda Nebeling
301-435-2841
nebelinl@mail.nih.gov
Health Services and Economics Research
Dr. Martin L. Brown
301-496-5716
brownm@dcpcepn.nci.nih.gov

Host Susceptibility Research
Dr. Elizabeth Gillanders
301-594-5868
lgilland@mail.nih.gov

Methods and Technologies Research
Dr. Mukesh Verma
301-594-7344
vermam@mail.nih.gov

Modified Risk Factors
Dr. Britt Reid
301-496-9600
reidbr@mail.nih.gov

Outcomes Research
Dr. Steven B. Clauser
301-451-4402
clausers@mail.nih.gov

Risk Factor Monitoring and Methods
Dr. Susan M. Krebs-Smith
301-496-4766
krebssms@mail.nih.gov

Statistical Methodology and Applications
Dr. Eric J. "Rocky" Feuer
301-496-5029
feuerr@exchange.nih.gov

Tobacco Control Research
Dr. Michele Bloch
301-402-5284
blochm@mail.nih.gov

Surveillance Systems
Dr. Zaria Tatalovich
301-402-4248
tatalovichzp@mail.nih.gov

Division of Cancer Prevention

DCP supports research to determine and reduce a person's risk of developing cancer, as well as research to develop and evaluate cancer screening procedures.
DCP Staff Directory

Biometry
Dr. Philip Prorok
301-496-7709
prorokp@mail.nih.gov

Breast and Gynecologic Cancer
Dr. Terri Cornelison
301-402-3963
cornelit@mail.nih.gov

Cancer Biomarkers
Dr. Sudhir Srivastava
301-496-3983
srivasts@mail.nih.gov

Chemopreventive Agent Development
Dr. Vernon Steele
301-594-0420
steelev@mail.nih.gov

Community Oncology & Prevention Trials
Dr. Lori Minasian
301-594-7868
minasilo@mail.nih.gov
Early Detection
Dr. Christine Berg
301-496-1071
bergc@mail.nih.gov

Gastrointestinal and Other Cancers
Dr. Asad Umar
301-594-7671
umara@mail.nih.gov

Lung and Upper Aerodigestive Cancer
Dr. Eva Szabo
301-435-2456
szaboe@mail.nih.gov

Nutritional Science
Dr. John Milner
301-496-0118
milnerj@mail.nih.gov

Prostate and Urologic Cancer
Dr. Howard Parnes
301-402-3606
parnesh@nih.gov

Division of Cancer Treatment and Diagnosis

DCTD supports the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients.
DCTD Staff Directory

Cancer Diagnosis Program
Dr. Barbara Conley
301-496-8639
barbara.conley@nih.gov

Cancer Imaging Program
Dr. Paula Jacobs
301-435-9181
jacobsp@mail.nih.gov

Cancer Therapy Evaluation Program
Dr. Jeffrey Abrams
301-496-2522
abramsj@ctep.nci.nih.gov

Developmental Therapeutics Program
Dr. Jerry Collins
301-496-8720
collinsje@mail.nih.gov
Complementary and Alternative Medicine
Dr. Jeffrey D. White
301-435-7980
jeffreyw@mail.nih.gov

Radiation Research Program
Dr. C. Norman Coleman
301-496-6111
coleman@mail.nih.gov

Translational Research Program (including SPOREs)
Dr. Toby Hecht
301-435-9043
hechtt@mail.nih.gov

NCI Centers, Offices, and Programs

Find NCI Program Director contacts for the following NCI Centers, Offices, and Selected Programs.

Center for Cancer Training (CCT)
CCT provides funding to support training and career development for cancer researchers working at institutions nationwide and also manages intramural training programs offered at NCI laboratories and offices.

Center to Reduce Cancer Health Disparities
CRCHD supports the reduction of cancer health disparities in diverse populations through research, training, and partnerships.

Center for Strategic Scientific Initiatives
CSSI provides support for innovative programs that include nanotechnology, clinical proteomics, biorepositories and biospecimens, and physical sciences cancer research.

Office of Biorepositories and Biospecimen Research
OBBR coordinates and manages the development of biospecimen-related policies and practices affecting NCI biorepositories.

Office of Cancer Clinical Proteomics
OCCPR supports the development of technologies and reagents that will advance our understanding of protein biology in cancer

The Cancer Genome Atlas Program
TCGA is a NCI initiative aimed at accelerating our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing.

Office of Cancer Genomics
OCG supports programs that will enhance our understanding of the molecular mechanisms of cancer.

Office of HIV and AIDS Malignancies
OHAM coordinates HIV/AIDS research throughout the NCI, including programs in AIDS-related cancer. 

Innovative Molecular Analysis Technologies Program
IMAT is a NCI initiative that supports the development of novel technologies that support clinical, laboratory, and epidemiology cancer research.

Office of Nanotechnology Research
OCNR directs the NCI Alliance for Nanotechnology in Cancer program that supports the application of nanotechnology to all aspects of cancer research.

Office of Physical Sciences-Oncology
OPSO supports the establishment of scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to develop novel approaches for cancer research.

Provocative Questions Program
PQ is a NCI initiative that intends to assemble a list of important questions, or problems that are paradoxes in cancer research that will stimulate research communities to use laboratory, clinical, and population sciences in new, effective, and imaginative ways. Inquiries about the PQ program are being managed by the Center for Strategic Scientific Initiatives.

Small Business & Small Business Technology Transfer
SBIR and STTR programs seek to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer.

Back to TopBack to Top